☆ 4.5 Article

Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm

BONE MARROW TRANSPLANTATION (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Hematology

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

Ephraim J. Fuchs et al.

Summary: HLA factors play an important role in the success of haploidentical transplantation. Disease-free survival is associated with matching status at individual HLA loci, with HLA-DRB1 and -DPB1 mismatches and HLA-C,-B leader, and -DQB1 matching being favorable. Considering HLA factors may help optimize the selection of haploidentical related donors.

BLOOD (2022)

添加到收藏夹

Article Oncology

Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies

Leo Luznik et al.

Summary: The study found that CNI-free approaches, such as ex vivo CD34 selection or in vivo post-transplant cyclophosphamide, can reduce the incidence of chronic GVHD after hematopoietic cell transplantation. However, these approaches did not improve patients' relapse-free survival. Tacrolimus and methotrexate with bone marrow graft remain an effective GVHD prophylaxis strategy.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation

Christopher J. Gibson et al.

Summary: Donor clonal hematopoiesis (CH) has a significant impact on clinical outcomes and graft alloimmune function in transplant recipients. DNMT3A-CH is associated with improved recipient survival and an augmented network of inflammatory cytokines in recipients. Different mutations may contribute to donor cell leukemia (DCL) in allogeneic hematopoietic cell transplantation.

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Hematology

Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial

Annoek E. C. Broers et al.

Summary: This study found that the combination of PT-Cy and a short course of CsA significantly reduces the occurrence of severe GVHD and improves GVHD-free, relapse-free survival in patients undergoing nonmyeloablative alloHSCT.

BLOOD ADVANCES (2022)

添加到收藏夹

Article Hematology

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

Hartmut Doehner et al.

Summary: The 2010 and 2017 editions of the European LeukemiaNet recommendations for AML diagnosis and management are widely recognized. There have been major advances in our understanding of AML, including disease classification updates, improvements in genomic diagnostics, and the development of new therapeutic agents. This update includes a revised genetic risk classification, response criteria, and treatment recommendations.

BLOOD (2022)

添加到收藏夹

Meeting Abstract Hematology

Long-Term Risk of Developing Immune Thrombocytopenia and Hematologic Neoplasia in Adults with Persistent, Isolated Mild Thrombocytopenia

Nardeen Ayad et al.

BLOOD (2022)

添加到收藏夹

Article Hematology

Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide

Rohtesh S. Mehta et al.

Summary: Despite the use of post-transplantation cyclophosphamide (PTCy), haploidentical donor hematopoietic cell transplantation (HCT) still has inferior outcomes compared to HLA-matched donor HCT. The haploidentical group had higher nonrelapse mortality and poorer progression-free survival and overall survival compared to the matched unrelated donor group. Relapse was the most common cause of death in all groups. The haploidentical group also had higher risk of infections, hemorrhagic cystitis, cardiovascular toxicities, and slower reconstitution of certain immune cells.

TRANSPLANTATION AND CELLULAR THERAPY (2022)

添加到收藏夹

Article Hematology

Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome

Anurag Singh et al.

Summary: This study evaluates the incidence and outcomes of non-CMV herpesvirus infections in recipients of haploidentical and fully matched transplantations with post-transplantation cyclophosphamide (PTCy). The results indicate a higher risk of NCHV infections in the PTCy groups, particularly in the HaploCy group. The development of NCHV infection is associated with increased treatment-related mortality.

TRANSPLANTATION AND CELLULAR THERAPY (2022)

添加到收藏夹

Article Biophysics

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

Jakob R. Passweg et al.

Summary: The number of Hematopoietic Cell Transplantations in Europe and collaborating countries has been on the rise, with a total of 48,512 HCT reported in 43,581 patients during 2019. The main indications were myeloid malignancies, lymphoid malignancies, and nonmalignant disorders. CAR-T cellular therapies also showed significant growth from 2017 to 2019. Over the past 30 years, there has been a substantial increase in the number of centers and countries performing HCT procedures, with more than 800,000 transplants reported overall.

BONE MARROW TRANSPLANTATION (2021)

添加到收藏夹

Article Hematology

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis

Mahasweta Gooptu et al.

Summary: After comparing outcomes of 2036 haploidentical and 284 matched unrelated donor (MUD) transplantations with posttransplant cyclophosphamide (PTCy) graft-versus-host disease (GVHD) prophylaxis, it was found that MUD transplants had lower acute GVHD and nonrelapse mortality rates, as well as higher disease-free and overall survival, especially in recipients of reduced-intensity regimens. However, no significant differences were observed in patients receiving myeloablative conditioning regimens, highlighting the importance of donor-recipient HLA matching for allogeneic transplantation.

BLOOD (2021)

添加到收藏夹

Article Hematology

Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation

Steffen Boettcher et al.

BLOOD (2020)

添加到收藏夹

Article Biophysics

Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Amandine Fayard et al.

BONE MARROW TRANSPLANTATION (2019)

添加到收藏夹

Review Hematology

Immune reconstitution after T-cell replete HLA-haploidentical transplantation

Shannon R. McCurdy et al.

SEMINARS IN HEMATOLOGY (2019)

添加到收藏夹

Article Hematology

NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications

Antonio Russo et al.

BLOOD (2018)

添加到收藏夹

Article Biophysics

Halfway there: the past, present and future of haploidentical transplantation

M. Slade et al.

BONE MARROW TRANSPLANTATION (2017)

添加到收藏夹

Article Immunology

Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation

Michael Slade et al.

TRANSPLANT INFECTIOUS DISEASE (2017)

添加到收藏夹

Article Hematology

Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT

Alienor Xhaard et al.

BLOOD ADVANCES (2017)

添加到收藏夹

Article Hematology

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

Andrew C. Harris et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)

添加到收藏夹

Article Hematology

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

Stefan O. Ciurea et al.

BLOOD (2015)

添加到收藏夹

Article Hematology

Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation

Alessandra Roberto et al.

BLOOD (2015)

添加到收藏夹

Article Oncology

Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

Yvette L. Kasamon et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Article Hematology

Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen Matched Unrelated and Related Donors

Antonio Di Stasi et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)

添加到收藏夹

Article Oncology

Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

Christopher G. Kanakry et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)

添加到收藏夹

Article Medicine, General & Internal

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

Siddhartha Jaiswal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Editorial Material Medicine, General & Internal

被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

添加到收藏夹

Article Oncology

T-Cell-Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation

Asad Bashey et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

添加到收藏夹

Article Hematology

Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial

Scott R. Solomon et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)

添加到收藏夹

Review Oncology

Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation

Leo Luznik et al.

SEMINARS IN ONCOLOGY (2012)

添加到收藏夹

Article Hematology

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

Leo Luznik et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)

添加到收藏夹

Review Biophysics

Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States

F. Aversa

BONE MARROW TRANSPLANTATION (2008)

添加到收藏夹

Review Biophysics

Haploidentical hematopoietic cell transplantation

L-P Koh et al.

BONE MARROW TRANSPLANTATION (2008)

添加到收藏夹

Review Medicine, General & Internal

Medical progress: Hematopoietic stem-cell transplantation

EA Copelan

NEW ENGLAND JOURNAL OF MEDICINE (2006)

添加到收藏夹

Article Medicine, General & Internal

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

SJ Pocock et al.

LANCET (2002)

添加到收藏夹

Article Medicine, General & Internal

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.

WI Bensinger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.